Aster Capital Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-238
Closed -$4.8K – 992
2026
Q2
$4.8K Buy
+238
New +$4.8K ﹤0.01% 727
2026
Q1
– Sell
-200
Closed -$5.36K – 836
2025
Q4
$5.36K Buy
+200
New +$5.15K ﹤0.01% 859
2025
Q1
– Sell
-2,869
Closed -$107K – 1233
2024
Q4
$107K Buy
+2,869
New +$131K 0.04% 375

Other funds holding AMPH

Aster Capital Management's AMPH Position: Q3 2026 in Review

Aster Capital Management sold out of Amphastar Pharmaceuticals (AMPH) in Q3 2026, closing a stake of 238 shares — an estimated $4.8K sold.

Aster Capital Management first reported a position in AMPH in Q4 2024 and held it in 3 quarters. The position peaked at $107K in Q4 2024. 227 funds tracked by Wall St. Rank hold AMPH as of Q3 2026.

  • Aster Capital Management reported no remaining Amphastar Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Aster Capital Management sold 238 Amphastar Pharmaceuticals shares in Q3 2026, an estimated $4.8K.
  • Aster Capital Management first reported a position in Amphastar Pharmaceuticals in Q4 2024 and held it in 3 quarters.
  • Aster Capital Management's Amphastar Pharmaceuticals position peaked at $107K in Q4 2024.
  • 227 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2026.

Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.